Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
November 5, 2024 - Page 2 of 3 - The Dermatology Digest
Subscribe
Search

Day: November 5, 2024

Phase 3 Data: Upadacitinib Shows Long-term Safety and Efficacy in Adolescents With AD

Adolescents with moderate to severe atopic dermatitis (AD) continue to do well on upadacitinib (Rinvoq, AbbVie) for up to 76 weeks with no new safety signals, according to data from three Phase 3 randomized clinical trials published in JAMA Dermatology. Fully 542 adolescents aged 12 to 17 received once-daily upadacitinib (15mg or 30mg) with or […]